Amicus Therapeutics, Inc.
FOLD
$7.61
$0.010.13%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -12.61% | -247.13% | 319.04% | 57.13% | 67.58% |
Total Depreciation and Amortization | 0.82% | -10.00% | -5.94% | -0.55% | 1.30% |
Total Amortization of Deferred Charges | 3.96% | 1.51% | 4.01% | 2.50% | 5.46% |
Total Other Non-Cash Items | 16.55% | -6.48% | -10.19% | 1.78% | -35.99% |
Change in Net Operating Assets | -583.39% | 113.74% | 0.54% | -496.48% | 149.70% |
Cash from Operations | -441.92% | 298.11% | 82.95% | -201.23% | 176.41% |
Capital Expenditure | -1,033.49% | 26.39% | 19.10% | 67.58% | 39.37% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 89.66% | -62.40% | -158.06% | 265.85% | -323.35% |
Cash from Investing | 82.42% | -61.15% | -159.50% | 255.94% | -391.59% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | 46.67% | 65.12% | -279.17% | 166.67% | 14.29% |
Issuance of Common Stock | -61.90% | -94.66% | -90.61% | 2,328.51% | -75.01% |
Repurchase of Common Stock | 96.34% | -1,323.91% | 70.34% | -65.80% | 89.93% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 96.58% | -1,166.55% | -93.97% | 2,222.52% | 93.56% |
Foreign Exchange rate Adjustments | 107.24% | 55.10% | 161.79% | -1,610.20% | 83.81% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 28.97% | -59.09% | -182.18% | 5,697.94% | 98.83% |